NCT05179226View on ClinicalTrials.gov

Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia

PHASE3RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Iron Deficiency, Anaemia in Children

Interventions

DRUG

Ferric Derisomaltose

All subjects will be treated with Ferric derisomaltose 20 mg/kg at baseline visit except for 12 subjects included in the PK-group, who will be treated with 10 mg/kg

Trial Locations (1)

33142

RECRUITING

Pharmacosmos Investigational Site, Miami